{"id":6674,"date":"2025-06-11T14:39:30","date_gmt":"2025-06-11T18:39:30","guid":{"rendered":"https:\/\/neuro.bluehat.hosting\/clinique\/alzheimers-disease\/"},"modified":"2026-01-09T17:00:13","modified_gmt":"2026-01-09T22:00:13","slug":"maladie-alzheimer","status":"publish","type":"page","link":"https:\/\/www.neuro-outaouais.com\/fr\/clinique\/maladie-alzheimer\/","title":{"rendered":"Maladie d\u2019Alzheimer"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"6674\" class=\"elementor elementor-6674 elementor-2497\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f39ccea e-con-full animated-slow e-flex e-con e-parent\" data-id=\"f39ccea\" data-element_type=\"container\" id=\"blur-image\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;animation&quot;:&quot;none&quot;,&quot;animation_delay&quot;:0}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-dd3ff18 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"dd3ff18\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Centre de traitement de la maladie d\u2019Alzheimer \u2013 Gatineau<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-42b75ad elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"42b75ad\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">En tant que centre de traitement de la maladie d\u2019Alzheimer desservant Gatineau, Ottawa et l\u2019ensemble de la r\u00e9gion de l\u2019Outaouais, la Clinique Neuro-Outaouais (CNO) offre une \u00e9valuation sp\u00e9cialis\u00e9e des troubles de la m\u00e9moire et des soins adapt\u00e9s pour les personnes atteintes d\u2019Alzheimer, quel que soit le stade de d\u00e9clin cognitif.\nNotre clinique de neurologie cognitive poss\u00e8de une expertise clinique reconnue et un acc\u00e8s \u00e0 des tests avanc\u00e9s de biomarqueurs, permettant un diagnostic plus pr\u00e9coce et plus pr\u00e9cis de la maladie d\u2019Alzheimer et l\u2019\u00e9laboration de plans de traitement fond\u00e9s sur les donn\u00e9es probantes.\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-0c0e3ab e-con-full elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile e-flex e-con e-parent\" data-id=\"0c0e3ab\" data-element_type=\"container\" id=\"horizontal-scroll\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-e5aed40 e-con-full e-flex e-con e-child\" data-id=\"e5aed40\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c91ba24 elementor-widget elementor-widget-heading\" data-id=\"c91ba24\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Une clinique des troubles cognitifs pour le diagnostic de la maladie d\u2019Alzheimer<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3ba6d82 elementor-widget elementor-widget-text-editor\" data-id=\"3ba6d82\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tLa maladie d\u2019Alzheimer est une maladie c\u00e9r\u00e9brale progressive et \u00e9ventuellement fatale. Elle repr\u00e9sente 60 \u00e0 80 % de tous les cas de d\u00e9mence. Les processus pathologiques commencent des d\u00e9cennies avant l\u2019apparition des sympt\u00f4mes, ce qui rend la d\u00e9tection pr\u00e9coce essentielle.\n\nLes troubles cognitifs peuvent se manifester de diff\u00e9rentes fa\u00e7ons, notamment :\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a19185b elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"a19185b\" data-element_type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Perte de m\u00e9moire<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Difficult\u00e9s \u00e0 s\u2019exprimer ou \u00e0 trouver les mots<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Probl\u00e8mes pour nommer ou reconna\u00eetre des personnes ou des objets<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Fluctuations importantes des capacit\u00e9s cognitives<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Changements comportementaux (d\u00e9sinhibition, apathie, comportements sociaux inappropri\u00e9s)<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Difficult\u00e9 \u00e0 accomplir des t\u00e2ches ou activit\u00e9s famili\u00e8res<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Apparition r\u00e9cente de parano\u00efa ou d\u2019isolement social<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f03ad28 elementor-widget elementor-widget-text-editor\" data-id=\"f03ad28\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tEn 2024, le National Institute on Aging et l\u2019Alzheimer\u2019s Association ont r\u00e9vis\u00e9 les crit\u00e8res diagnostiques de la maladie d\u2019Alzheimer afin d\u2019exiger une confirmation biologique du processus pathologique \u00e0 l\u2019aide de diff\u00e9rents biomarqueurs.\n\nLes biomarqueurs de base (Core 1) comprennent la TEP amylo\u00efde, les biomarqueurs du liquide c\u00e9phalorachidien (A\u03b242\/40, p-tau181\/A\u03b242, tau total\/A\u03b242) et les biomarqueurs s\u00e9riques (p-tau217). Ces marqueurs peuvent \u00eatre pr\u00e9sents avant m\u00eame l\u2019apparition des sympt\u00f4mes.\n\n\u00c0 l\u2019heure actuelle, la CNO utilise les biomarqueurs du LCR et\/ou le niveau s\u00e9rique de p-tau217 pour confirmer la pr\u00e9sence de la maladie d\u2019Alzheimer.\n\nLes biomarqueurs Core 2 incluent l\u2019analyse MTBR-tau243, p-tau205, la TEP-tau, ainsi que NFL, GFAP et l\u2019IRM c\u00e9r\u00e9brale. Ils sont utilis\u00e9s pour le stade \u00e9volutif, le pronostic et l\u2019\u00e9valuation de la r\u00e9ponse au traitement.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-067117e e-con-full e-flex e-con e-child\" data-id=\"067117e\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9e1a4aa elementor-widget elementor-widget-spacer\" data-id=\"9e1a4aa\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-02eb947 elementor-widget elementor-widget-html\" data-id=\"02eb947\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<script>\n\/\/ Scroll to top on page load\nwindow.onload = function() {\n    window.scrollTo(0, 0);\n};\n\n\/\/ Alternative that works with turbolinks (if you're using that)\ndocument.addEventListener('DOMContentLoaded', function() {\n    window.scrollTo(0, 0);\n});\n<\/script>\n<script>\ndocument.addEventListener('DOMContentLoaded', function () {\n    const scrollContainer = document.querySelector('#horizontal-scroll');\n\n    \/\/ Add a check to ensure the element exists before trying to manipulate it\n    if (!scrollContainer) {\n        console.warn('Element #horizontal-scroll not found. Script will not run.');\n        return;\n    }\n\n    let lastScrollTop = 0;\n    let isScrollingDown = false;\n\n    \/\/ Define key scroll points\n    const activationScrollPoint = 300; \/\/ When the container starts to appear\n    const fullRevealScrollPoint = 800; \/\/ When the container is fully visible (right: 0%)\n    const stickToTopScrollPoint = 900; \/\/ When the container transitions from fixed to sticky\/absolute at the top\n\n    \/\/ Initial state setup\n    scrollContainer.style.opacity = '0';\n    scrollContainer.style.right = '-100%'; \/\/ Start fully off-screen to the right\n    scrollContainer.style.position = 'fixed';\n    scrollContainer.style.top = '0px'; \/\/ Important: Keep top at 0px for the fixed state for smooth transition later\n\n    \/\/ Cache the initial transform if any, or set it up for horizontal movement\n    \/\/ Since we want horizontal reveal, we'll control 'right' directly.\n    \/\/ If you had vertical centering, 'transform: translateY(-50%)' would go here, but we're sticking to top.\n\n    window.addEventListener('scroll', function () {\n        const scrollTop = window.pageYOffset || document.documentElement.scrollTop;\n        isScrollingDown = scrollTop > lastScrollTop;\n        lastScrollTop = scrollTop <= 0 ? 0 : scrollTop;\n\n        \/\/ --- Phase 1: Reveal and Hide (fixed position) ---\n        if (scrollTop >= activationScrollPoint && scrollTop < fullRevealScrollPoint) {\n            \/\/ Calculate progress for revealing\n            const progress = (scrollTop - activationScrollPoint) \/ (fullRevealScrollPoint - activationScrollPoint);\n            \/\/ Ensure progress is between 0 and 1\n            const clampedProgress = Math.min(1, Math.max(0, progress));\n\n            \/\/ Smoothly slide in from right (-100% to 0%) and fade in (0 to 1)\n            scrollContainer.style.opacity = clampedProgress.toString();\n            \/\/ Calculate right position: from -100% to 0% as progress goes from 0 to 1\n            \/\/ A more direct way: when progress is 0, right is -100%. When progress is 1, right is 0%.\n            \/\/ (1 - clampedProgress) means it goes from 1 to 0. So multiply by -100% to get 0 to -100%\n            scrollContainer.style.right = `${(1 - clampedProgress) * -100}%`;\n            scrollContainer.style.position = 'fixed';\n            scrollContainer.style.top = '0px'; \/\/ Maintain top position during fixed reveal\n\n        }\n        \/\/ --- Phase 2: Fully Visible and Sticky\/Absolute ---\n        else if (scrollTop >= fullRevealScrollPoint) {\n            scrollContainer.style.opacity = '1';\n            scrollContainer.style.right = '0px'; \/\/ Ensure it's fully visible\n\n            \/\/ Check if we should stick to the top or scroll with content\n            if (scrollTop >= stickToTopScrollPoint) {\n                \/\/ Once beyond stickToTopScrollPoint, change to absolute\n                \/\/ and set its top to the current scroll position so it moves with the page\n                scrollContainer.style.position = 'absolute';\n                scrollContainer.style.top = `${stickToTopScrollPoint}px`; \/\/ Stick to this specific scroll position\n            } else {\n                \/\/ Between fullRevealScrollPoint and stickToTopScrollPoint, it's fixed at the top\n                scrollContainer.style.position = 'fixed';\n                scrollContainer.style.top = '0px';\n            }\n        }\n        \/\/ --- Phase 3: Hidden (above activation point) ---\n        else {\n            scrollContainer.style.opacity = '0';\n            scrollContainer.style.right = '-100%'; \/\/ Fully hidden\n            scrollContainer.style.position = 'fixed';\n            scrollContainer.style.top = '0px'; \/\/ Reset for next reveal\n        }\n    });\n});\n<\/script>\n\n<style>\n#horizontal-scroll {\n    position: fixed; \/* Initial state, JS will change it *\/\n    right: -100%;    \/* Initial state, JS will change it *\/\n    top: 0;          \/* Consistent top position *\/\n    width: 100%;     \/* Example: or a specific pixel width *\/\n    box-sizing: border-box;\n    z-index: 9999;\n    opacity: 0;\n    \/* IMPORTANT: Remove CSS transitions for properties controlled by JS *\/\n    transition: none; \/* Disables all transitions for #horizontal-scroll *\/\n}\n<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7c36377 elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile e-flex e-con-boxed e-con e-parent\" data-id=\"7c36377\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-bc65031 e-con-full scroll-fade e-flex e-con e-parent\" data-id=\"bc65031\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-dbd431f e-con-full e-flex e-con e-child\" data-id=\"dbd431f\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5744606 elementor-widget elementor-widget-heading\" data-id=\"5744606\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Une clinique des troubles cognitifs pour le diagnostic de la maladie d\u2019Alzheimer<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4aca1f8 elementor-widget elementor-widget-text-editor\" data-id=\"4aca1f8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tLa maladie d\u2019Alzheimer est une maladie c\u00e9r\u00e9brale progressive et \u00e9ventuellement fatale. Elle repr\u00e9sente 60 \u00e0 80 % de tous les cas de d\u00e9mence. Les processus pathologiques commencent des d\u00e9cennies avant l\u2019apparition des sympt\u00f4mes, ce qui rend la d\u00e9tection pr\u00e9coce essentielle.\n\nLes troubles cognitifs peuvent se manifester de diff\u00e9rentes fa\u00e7ons, notamment :\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0fe948b elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"0fe948b\" data-element_type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Perte de m\u00e9moire<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Difficult\u00e9s \u00e0 s\u2019exprimer ou \u00e0 trouver les mots<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Probl\u00e8mes pour nommer ou reconna\u00eetre des personnes ou des objets<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Fluctuations importantes des capacit\u00e9s cognitives<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Changements comportementaux (d\u00e9sinhibition, apathie, comportements sociaux inappropri\u00e9s)<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Difficult\u00e9 \u00e0 accomplir des t\u00e2ches ou activit\u00e9s famili\u00e8res<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-circle\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Apparition r\u00e9cente de parano\u00efa ou d\u2019isolement social<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f063749 elementor-widget elementor-widget-text-editor\" data-id=\"f063749\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tEn 2024, le National Institute on Aging et l\u2019Alzheimer\u2019s Association ont r\u00e9vis\u00e9 les crit\u00e8res diagnostiques de la maladie d\u2019Alzheimer afin d\u2019exiger une confirmation biologique du processus pathologique \u00e0 l\u2019aide de diff\u00e9rents biomarqueurs.\n\nLes biomarqueurs de base (Core 1) comprennent la TEP amylo\u00efde, les biomarqueurs du liquide c\u00e9phalorachidien (A\u03b242\/40, p-tau181\/A\u03b242, tau total\/A\u03b242) et les biomarqueurs s\u00e9riques (p-tau217). Ces marqueurs peuvent \u00eatre pr\u00e9sents avant m\u00eame l\u2019apparition des sympt\u00f4mes.\n\n\u00c0 l\u2019heure actuelle, la CNO utilise les biomarqueurs du LCR et\/ou le niveau s\u00e9rique de p-tau217 pour confirmer la pr\u00e9sence de la maladie d\u2019Alzheimer.\n\nLes biomarqueurs Core 2 incluent l\u2019analyse MTBR-tau243, p-tau205, la TEP-tau, ainsi que NFL, GFAP et l\u2019IRM c\u00e9r\u00e9brale. Ils sont utilis\u00e9s pour le stade \u00e9volutif, le pronostic et l\u2019\u00e9valuation de la r\u00e9ponse au traitement.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1038e62 e-con-full e-flex e-con e-child\" data-id=\"1038e62\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-36a9bda elementor-widget elementor-widget-spacer\" data-id=\"36a9bda\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ba81953 elementor-widget elementor-widget-html\" data-id=\"ba81953\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<script>\ndocument.addEventListener(\"scroll\", function () {\n    document.querySelectorAll(\".scroll-fade\").forEach(el => {\n        const rect = el.getBoundingClientRect();\n        const windowHeight = window.innerHeight;\n\n        if (rect.top < windowHeight && rect.bottom > 0) {\n            let progress = 1 - rect.top \/ windowHeight;\n            progress = Math.min(Math.max(progress, 0), 1);\n\n            el.style.opacity = progress;\n            el.style.transform = `translateX(${1200 - (progress * 1200)}px)`;\n        }\n    });\n});\n<\/script>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-62d63a8 e-con-full e-flex e-con e-parent\" data-id=\"62d63a8\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-f637adf e-con-full e-flex e-con e-child\" data-id=\"f637adf\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-21514d4 e-con-full e-flex e-con e-child\" data-id=\"21514d4\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3bc5935 animated-slow elementor-widget__width-initial elementor-invisible elementor-widget elementor-widget-image\" data-id=\"3bc5935\" data-element_type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInLeft&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"512\" height=\"341\" src=\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png\" class=\"attachment-full size-full wp-image-8802\" alt=\"nurse taking blood pressure reading on patient at CNO\" srcset=\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png 512w, https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image-300x200.png 300w\" sizes=\"(max-width: 512px) 100vw, 512px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6236f58 e-con-full e-flex e-con e-child\" data-id=\"6236f58\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-50d9326 elementor-widget elementor-widget-heading\" data-id=\"50d9326\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u00c9valuation de la perte de m\u00e9moire &amp; traitement de la maladie d\u2019Alzheimer \u2013 \u00c9valuations neurologiques \u00e0 la CNO<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c25943e elementor-widget elementor-widget-text-editor\" data-id=\"c25943e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tL\u2019\u00e9quipe de neurologues et d\u2019infirmi\u00e8res de la CNO r\u00e9alise une \u00e9valuation neurologique compl\u00e8te afin de d\u00e9terminer la pr\u00e9sence d\u2019un d\u00e9clin cognitif et d\u2019en identifier les causes possibles.\n<br><br>\nActuellement, il n\u2019existe aucun rem\u00e8de \u00e0 la maladie d\u2019Alzheimer. Les traitements modificateurs de l\u2019\u00e9volution de la maladie sont r\u00e9cemment devenus disponibles au Canada.\n<br><br>\n\u00c0 la CNO, nous utilisons notamment les anticorps monoclonaux anti-b\u00eata-amylo\u00efde lecanemab et donanemab, administr\u00e9s par voie intraveineuse toutes les 2 et 4 semaines respectivement. Les essais cliniques contr\u00f4l\u00e9s ont d\u00e9montr\u00e9 que ces traitements permettent une normalisation de l\u2019imagerie amylo\u00efde par TEP ainsi qu\u2019une r\u00e9duction significative de la vitesse du d\u00e9clin cognitif.\n<br><br>\nLes meilleurs r\u00e9sultats sont observ\u00e9s chez les patients se trouvant \u00e0 un stade pr\u00e9coce de l\u2019\u00e9volution de la maladie d\u2019Alzheimer, certains pr\u00e9sentant m\u00eame une am\u00e9lioration de leurs fonctions cognitives. Bien que tr\u00e8s prometteurs, ces nouveaux traitements comportent des risques de complications. C\u2019est pourquoi une s\u00e9lection rigoureuse des patients et un suivi \u00e9troit par une \u00e9quipe sp\u00e9cialis\u00e9e sont essentiels.\n<br><br>\n\u00c0 la CNO, nous ne nous limitons pas \u00e0 identifier les personnes atteintes de la maladie d\u2019Alzheimer susceptibles de b\u00e9n\u00e9ficier de ces nouvelles th\u00e9rapies en toute s\u00e9curit\u00e9. Nous administrons \u00e9galement ces traitements au sein de notre <a href=\"https:\/\/www.neuro-outaouais.com\/fr\/clinique-infusion\/\">clinique d\u2019infusion<\/a> et assurons l\u2019ensemble du suivi et de la surveillance clinique requis.\n<br><br>\nLes essais cliniques repr\u00e9sentent une autre option th\u00e9rapeutique pour les personnes atteintes de maladies neurologiques chroniques. La CNO participe activement \u00e0 la recherche clinique dans un large \u00e9ventail de troubles neurologiques.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4332c1b e-con-full e-flex e-con e-parent\" data-id=\"4332c1b\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-3f5576c e-con-full animated-slow e-flex elementor-invisible e-con e-child\" data-id=\"3f5576c\" data-element_type=\"container\" data-settings=\"{&quot;animation&quot;:&quot;fadeIn&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0df680c elementor-widget elementor-widget-heading\" data-id=\"0df680c\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">La rTMS pour le traitement de la maladie d\u2019Alzheimer \u2013 \u00c0 notre clinique de neurologie cognitive<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ebbaaaa elementor-widget elementor-widget-text-editor\" data-id=\"ebbaaaa\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tLa stimulation magn\u00e9tique transcr\u00e2nienne r\u00e9p\u00e9titive (rTMS) est une technique non invasive de neuromodulation utilisant un champ magn\u00e9tique pour g\u00e9n\u00e9rer de br\u00e8ves impulsions au niveau du syst\u00e8me nerveux central. Ces impulsions induisent un courant \u00e9lectrique l\u00e9ger dans des zones sp\u00e9cifiques du cortex, influen\u00e7ant l\u2019activit\u00e9 synaptique, la connectivit\u00e9 et la neuroplasticit\u00e9 dans les r\u00e9gions du cerveau impliqu\u00e9es dans les fonctions cognitives.\n<br><br>\nLes \u00e9tudes r\u00e9centes montrent que la rTMS peut am\u00e9liorer certaines fonctions cognitives chez les personnes atteintes de la maladie d\u2019Alzheimer. Bien qu\u2019elle semble s\u00fbre et possiblement b\u00e9n\u00e9fique, des recherches suppl\u00e9mentaires sont n\u00e9cessaires pour mieux comprendre et optimiser cette intervention.\n<br><br>\nLa CNO propose des <a href=\"https:\/\/www.neuro-outaouais.com\/fr\/smtr\/\">traitements de rTMS<\/a> pour les personnes atteintes de la maladie d\u2019Alzheimer. Toutefois, comme il s\u2019agit encore d\u2019un traitement exp\u00e9rimental, il n\u2019est pas couvert par le syst\u00e8me public de sant\u00e9.<br>\n<h3>Recherche clinique \u00e0 notre clinique de la maladie d\u2019Alzheimer<\/h3>\nLa CNO est engag\u00e9e dans la recherche clinique portant sur de nombreux troubles neurologiques et affections connexes, y compris la <a href=\"https:\/\/www.neuro-outaouais.com\/fr\/essais-cliniques\/alzheimer\/\">recherche sur la maladie d\u2019Alzheimer<\/a>. En tant que clinique de pr\u00e9vention de la maladie d\u2019Alzheimer et centre de traitement de la d\u00e9mence, nous visons \u00e0 am\u00e9liorer l\u2019acc\u00e8s \u00e0 des diagnostics avanc\u00e9s, \u00e0 de nouvelles th\u00e9rapies et \u00e0 des essais cliniques appliqu\u00e9s au contexte r\u00e9el.<br>\n<h3>Prenez rendez-vous pour une \u00e9valuation de la m\u00e9moire \u00e0 notre clinique de la maladie d\u2019Alzheimer \u00e0 Gatineau<\/h3>\nSi vous ou un proche pr\u00e9sentez des changements de m\u00e9moire ou un d\u00e9clin cognitif, notre \u00e9quipe peut offrir une \u00e9valuation compl\u00e8te.\n<br><br>\nPour discuter du diagnostic et des options de traitement de la maladie d\u2019Alzheimer, <a href=\"https:\/\/www.neuro-outaouais.com\/fr\/contact\/\">contactez-nous d\u00e8s aujourd\u2019hui<\/a>.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6ab5983 e-con-full animated-slow e-flex elementor-invisible e-con e-child\" data-id=\"6ab5983\" data-element_type=\"container\" data-settings=\"{&quot;animation&quot;:&quot;fadeIn&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1f89885 animated-slow elementor-invisible elementor-widget elementor-widget-image\" data-id=\"1f89885\" data-element_type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInRight&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1800\" height=\"1201\" src=\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/06\/alzheimers03.jpg\" class=\"attachment-full size-full wp-image-2551\" alt=\"Alzheimer&#039;s disease patient in cognitive therapy at Neuro-Outaouais\" srcset=\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/06\/alzheimers03.jpg 1800w, https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/06\/alzheimers03-300x200.jpg 300w, https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/06\/alzheimers03-1024x683.jpg 1024w, https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/06\/alzheimers03-768x512.jpg 768w, https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/06\/alzheimers03-1536x1025.jpg 1536w\" sizes=\"(max-width: 1800px) 100vw, 1800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Centre de traitement de la maladie d\u2019Alzheimer \u2013 Gatineau En tant que centre de traitement de la maladie d\u2019Alzheimer desservant Gatineau, Ottawa et l\u2019ensemble de la r\u00e9gion de l\u2019Outaouais, la Clinique Neuro-Outaouais (CNO) offre une \u00e9valuation sp\u00e9cialis\u00e9e des troubles de la m\u00e9moire et des soins adapt\u00e9s pour les personnes atteintes d\u2019Alzheimer, quel que soit le [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":6607,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"wf_page_folders":[9],"class_list":["post-6674","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Traitement de la maladie d\u2019Alzheimer \u00e0 Gatineau \u2013 \u00c9valuation de la m\u00e9moire et de la d\u00e9mence | CNO<\/title>\n<meta name=\"description\" content=\"Clinique de la maladie d\u2019Alzheimer offrant \u00e9valuation de la m\u00e9moire, diagnostic pr\u00e9coce par biomarqueurs et options de traitement avanc\u00e9es \u00e0 Gatineau.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Traitement de la maladie d\u2019Alzheimer \u00e0 Gatineau \u2013 \u00c9valuation de la m\u00e9moire et de la d\u00e9mence | CNO\" \/>\n<meta property=\"og:description\" content=\"Clinique de la maladie d\u2019Alzheimer offrant \u00e9valuation de la m\u00e9moire, diagnostic pr\u00e9coce par biomarqueurs et options de traitement avanc\u00e9es \u00e0 Gatineau.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Neuro-Outaouais\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-09T22:00:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"512\" \/>\n\t<meta property=\"og:image:height\" content=\"341\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/\",\"url\":\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/\",\"name\":\"Traitement de la maladie d\u2019Alzheimer \u00e0 Gatineau \u2013 \u00c9valuation de la m\u00e9moire et de la d\u00e9mence | CNO\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuro-outaouais.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png\",\"datePublished\":\"2025-06-11T18:39:30+00:00\",\"dateModified\":\"2026-01-09T22:00:13+00:00\",\"description\":\"Clinique de la maladie d\u2019Alzheimer offrant \u00e9valuation de la m\u00e9moire, diagnostic pr\u00e9coce par biomarqueurs et options de traitement avanc\u00e9es \u00e0 Gatineau.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#primaryimage\",\"url\":\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png\",\"contentUrl\":\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.neuro-outaouais.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinique\",\"item\":\"https:\/\/www.neuro-outaouais.com\/fr\/clinique\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Maladie d\u2019Alzheimer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuro-outaouais.com\/#website\",\"url\":\"https:\/\/www.neuro-outaouais.com\/\",\"name\":\"My blog\",\"description\":\"We are a non-profit dedicated to expanding the breadth of medical care for people with neurological diseases.\",\"publisher\":{\"@id\":\"https:\/\/www.neuro-outaouais.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuro-outaouais.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.neuro-outaouais.com\/#organization\",\"name\":\"My blog\",\"url\":\"https:\/\/www.neuro-outaouais.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.neuro-outaouais.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/04\/21f72584-071b-4bae-ab40-e19dc1dfa7ff.png\",\"contentUrl\":\"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/04\/21f72584-071b-4bae-ab40-e19dc1dfa7ff.png\",\"width\":180,\"height\":89,\"caption\":\"My blog\"},\"image\":{\"@id\":\"https:\/\/www.neuro-outaouais.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Traitement de la maladie d\u2019Alzheimer \u00e0 Gatineau \u2013 \u00c9valuation de la m\u00e9moire et de la d\u00e9mence | CNO","description":"Clinique de la maladie d\u2019Alzheimer offrant \u00e9valuation de la m\u00e9moire, diagnostic pr\u00e9coce par biomarqueurs et options de traitement avanc\u00e9es \u00e0 Gatineau.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/","og_locale":"fr_CA","og_type":"article","og_title":"Traitement de la maladie d\u2019Alzheimer \u00e0 Gatineau \u2013 \u00c9valuation de la m\u00e9moire et de la d\u00e9mence | CNO","og_description":"Clinique de la maladie d\u2019Alzheimer offrant \u00e9valuation de la m\u00e9moire, diagnostic pr\u00e9coce par biomarqueurs et options de traitement avanc\u00e9es \u00e0 Gatineau.","og_url":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/","og_site_name":"Neuro-Outaouais","article_modified_time":"2026-01-09T22:00:13+00:00","og_image":[{"width":512,"height":341,"url":"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/","url":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/","name":"Traitement de la maladie d\u2019Alzheimer \u00e0 Gatineau \u2013 \u00c9valuation de la m\u00e9moire et de la d\u00e9mence | CNO","isPartOf":{"@id":"https:\/\/www.neuro-outaouais.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#primaryimage"},"image":{"@id":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png","datePublished":"2025-06-11T18:39:30+00:00","dateModified":"2026-01-09T22:00:13+00:00","description":"Clinique de la maladie d\u2019Alzheimer offrant \u00e9valuation de la m\u00e9moire, diagnostic pr\u00e9coce par biomarqueurs et options de traitement avanc\u00e9es \u00e0 Gatineau.","breadcrumb":{"@id":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#primaryimage","url":"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png","contentUrl":"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/12\/new-image.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuro-outaouais.com\/clinic\/alzheimers-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neuro-outaouais.com\/"},{"@type":"ListItem","position":2,"name":"Clinique","item":"https:\/\/www.neuro-outaouais.com\/fr\/clinique\/"},{"@type":"ListItem","position":3,"name":"Maladie d\u2019Alzheimer"}]},{"@type":"WebSite","@id":"https:\/\/www.neuro-outaouais.com\/#website","url":"https:\/\/www.neuro-outaouais.com\/","name":"My blog","description":"We are a non-profit dedicated to expanding the breadth of medical care for people with neurological diseases.","publisher":{"@id":"https:\/\/www.neuro-outaouais.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuro-outaouais.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.neuro-outaouais.com\/#organization","name":"My blog","url":"https:\/\/www.neuro-outaouais.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.neuro-outaouais.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/04\/21f72584-071b-4bae-ab40-e19dc1dfa7ff.png","contentUrl":"https:\/\/www.neuro-outaouais.com\/wp-content\/uploads\/2025\/04\/21f72584-071b-4bae-ab40-e19dc1dfa7ff.png","width":180,"height":89,"caption":"My blog"},"image":{"@id":"https:\/\/www.neuro-outaouais.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/pages\/6674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/comments?post=6674"}],"version-history":[{"count":63,"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/pages\/6674\/revisions"}],"predecessor-version":[{"id":8971,"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/pages\/6674\/revisions\/8971"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/pages\/6607"}],"wp:attachment":[{"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/media?parent=6674"}],"wp:term":[{"taxonomy":"wf_page_folders","embeddable":true,"href":"https:\/\/www.neuro-outaouais.com\/fr\/wp-json\/wp\/v2\/wf_page_folders?post=6674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}